ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 23 filers reported holding ATYR PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,608,098 | -27.4% | 2,283,606 | -0.7% | 0.00% | – |
Q2 2023 | $4,969,542 | +13.0% | 2,300,714 | +9.9% | 0.00% | – |
Q1 2023 | $4,397,940 | +76.1% | 2,094,257 | +83.7% | 0.00% | – |
Q4 2022 | $2,496,876 | -26.9% | 1,140,126 | +0.1% | 0.00% | – |
Q3 2022 | $3,418,000 | +6.0% | 1,139,533 | 0.0% | 0.00% | – |
Q2 2022 | $3,225,000 | -47.1% | 1,139,533 | 0.0% | 0.00% | – |
Q1 2022 | $6,097,000 | -26.7% | 1,139,533 | +2.4% | 0.00% | – |
Q4 2021 | $8,315,000 | +1.0% | 1,113,191 | +22.8% | 0.00% | – |
Q3 2021 | $8,234,000 | +183.5% | 906,741 | +52.3% | 0.00% | – |
Q2 2021 | $2,904,000 | +121.2% | 595,202 | +101.7% | 0.00% | – |
Q1 2021 | $1,313,000 | +35.2% | 295,105 | +18.0% | 0.00% | – |
Q4 2020 | $971,000 | +28.6% | 250,147 | +7.0% | 0.00% | – |
Q3 2020 | $755,000 | -23.4% | 233,850 | +5.4% | 0.00% | – |
Q2 2020 | $985,000 | +58.6% | 221,938 | 0.0% | 0.00% | – |
Q1 2020 | $621,000 | -10.0% | 221,938 | +34.0% | 0.00% | – |
Q4 2019 | $690,000 | +18.4% | 165,583 | -0.5% | 0.00% | – |
Q3 2019 | $583,000 | – | 166,483 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 282,420 | $1,511,000 | 2.38% |
Tikvah Management LLC | 1,350,833 | $7,227,000 | 2.31% |
Stonepine Capital Management, LLC | 601,580 | $3,218,000 | 1.34% |
VR Adviser, LLC | 1,398,889 | $7,484,000 | 1.21% |
TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $5,957,000 | 1.19% |
Deep Track Capital, LP | 1,028,515 | $5,503,000 | 0.35% |
FEDERATED HERMES, INC. | 5,222,250 | $27,939,000 | 0.06% |
Alyeska Investment Group, L.P. | 760,798 | $4,070,000 | 0.04% |
Ikarian Capital, LLC | 37,017 | $197,000 | 0.03% |
Baker Brothers Advisors | 625,000 | $3,344,000 | 0.02% |